1Bacon BR. Powell I,M, Adams PC. et al. Molecular medicine and hemochromatosis: at the crossroads[ J]. Gastroenterology 1999. 116 ( 1 ) : 193-207.
2George DK. Goldwurn S. Macdonald GA. et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis associated with increased fibrosis [ J ]. Gastroenterology. 1998, 114 ( 2 ) : 311-318.
3Bonkovsky HL, Jawaid Q, Tortorelli K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis [ J ]. J Hepatol, 1999, 31 (2) :421-429.
4Moirand R. Mendler MH, Guillygomareh A. et al. Non-alcoholic steatohepatitis with iron : part of insulin resistance-associated hepatic iron overload?[J]. J Hepatol. 2000. 33 (3) : 1024-1026.
5Fargion S, Mattioli M, Fracanzani AL, et al. Hypeerferritinemi iron overload, and muhiple metabolic alterations identify patients at risk for non-alcoholic steatohepatitis[ J]. Am J Gastroemerol. 2001 .96( 8 ) : 2448-2455.
6Chitturi S, Farrell GC, Liddle C, et al. HFE mutations, hepatic iron. and fibrosis: elhnic-specific association of NASH with C282Y but uot with fibrotic severity [J]. Hepatology, 2002,36(1): 142-149.
7Asberg A, Thorstensen K, Hveem K. et al. Hereditary hemochromatosis: the clinical and significance of the S65D mutation[J]. Genet Test, 2002, 6( 1 ) : 59-62.
8Younossi ZM. Gramlich T. Bacon BR. et al. Hepatic. iron and nonalcoholic steatohepatitis [ J ]. Hepatology, 1999. 30 ( 4 ) : 847-850.
9Washington K. gright K. Shvr Y, et al. Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver[ J ]. Hepatology, 2000. 31(7): 822-828.
10Brgianesi E. Leone N, Vanni E. et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic eirrhosis to hepatocellular carcinoma[J]. Gastroenterology, 2002. 123 ( 1 ) : 134-140.
9Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes[J]. Nature, 2005,436(7049) : 356-362.
